There were 606 press releases posted in the last 24 hours and 437,904 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Principia Presents Updated Positive Data of Rilzabrutinib for Immune Thrombocytopenia in Ongoing Phase 1/2 Trial

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image